Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Accumulated Deficit	Treasury Stock	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022		16,210,776
Beginning balance at Dec. 31, 2022	$ 63,631	$ 16	$ 109,138	$ 11,753	$ (58,033)	$ 757
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in asset acquisition (in shares)		100,000
Issuance of common stock in asset acquisition	1,000	$ 1	999
Repurchases of common shares (in shares)		(69,628)
Repurchases of common shares	(588)				(588)
Issuance of common stock to convert outstanding convertible notes (in shares)		800,000
Issuance of common stock to convert outstanding convertible notes	2,400	$ 1	2,399
Issuance of common stock upon exercise of warrants (in shares)		400,000
Issuance of common stock upon exercise of warrants	1,200		1,200
Issuance of common stock upon stock options cashless exercise (in shares)		603,881
Issuance of warrants with unsecured promissory note	398		398
Treasury shares repurchased to satisfy tax withholding obligations	(5,379)				(5,379)
Unrealized gain (loss) on marketable securities	(2,201)					(2,201)
Stock-based compensation	3,998		3,998
Net loss	(8,031)			(8,031)
Ending balance (in shares) at Sep. 30, 2023		18,045,029
Ending balance at Sep. 30, 2023	56,428	$ 18	118,132	3,722	(64,000)	(1,444)
Beginning balance (in shares) at Jun. 30, 2023		16,845,029
Beginning balance at Jun. 30, 2023	59,257	$ 17	113,789	8,863	(64,000)	588
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock to convert outstanding convertible notes (in shares)		800,000
Issuance of common stock to convert outstanding convertible notes	2,400	$ 1	2,399
Issuance of common stock upon exercise of warrants (in shares)		400,000
Issuance of common stock upon exercise of warrants	1,200		1,200
Unrealized gain (loss) on marketable securities	(2,032)					(2,032)
Stock-based compensation	744		744
Net loss	(5,141)			(5,141)
Ending balance (in shares) at Sep. 30, 2023		18,045,029
Ending balance at Sep. 30, 2023	$ 56,428	$ 18	118,132	3,722	(64,000)	(1,444)
Beginning balance (in shares) at Dec. 31, 2023	18,045,029	18,045,029
Beginning balance at Dec. 31, 2023	$ 49,383	$ 18	118,694	(5,029)	(64,000)	(300)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for cash, net of offering cost (in shares)		1,033,500
Issuance of common stock for cash, net of offering cost	4,624		4,624
Unrealized gain (loss) on marketable securities	103					103
Stock-based compensation	3,021		3,021
Net loss	$ (19,005)			(19,005)
Ending balance (in shares) at Sep. 30, 2024	19,078,529	19,078,529
Ending balance at Sep. 30, 2024	$ 38,126	$ 18	126,339	(24,034)	(64,000)	(197)
Beginning balance (in shares) at Jun. 30, 2024		19,078,529
Beginning balance at Jun. 30, 2024	44,076	$ 18	125,703	(17,447)	(64,000)	(198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized gain (loss) on marketable securities	1					1
Stock-based compensation	636		636
Net loss	$ (6,587)			(6,587)
Ending balance (in shares) at Sep. 30, 2024	19,078,529	19,078,529
Ending balance at Sep. 30, 2024	$ 38,126	$ 18	$ 126,339	$ (24,034)	$ (64,000)	$ (197)